Cardiogenic Shock Acute
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiogenic Shock Acute trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiogenic Shock Acute trials you may qualify forThis study will evaluate the feasibility and safety of achieving therapeutic concentrations of beta-hydroxybutyrate using continuous infusion of D-beta-hydroxyb…
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used worldwide to treat severe cardiogenic shock. The survival rate of these pa…
The goal of this observational study is to learn whether information collected during routine hospital care, together with blood and urine samples, can help doc…
An observational cohort study to evaluate the benefit of functional parameters, radiomics and blood biomarkers to predict the outcome of patients with acute hea…
Rationale: Pump failure due to acute myocardial infarction (AMI) can lead to cardiogenic shock (CS): a state of low blood flow to end-organs with subsequent mul…
This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical c…
The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated…
This is a retrospective study from double center: Xuzhou Central Hospital and The First People's Hospital of Yancheng. Acute myocardial infarction (AMI) were sc…
A prospective, multi-center, open label, randomized controlled, superiority trial to compare clinical outcomes between routine distal perfusion catheter (DPC) i…